SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Rat dog micro-cap picks--now moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bucky Katt who started this subject2/27/2004 9:38:00 AM
From: manny t   of 1338
 
HQNT,

More PR's:

PRESS RELEASE: H-Quotient's Clinical Demonstrations Increase More Than Tenfold: Primary Precursor of Increased Sales

--------------------------------------------------------------------------------
Fri Feb 27 09:22:39 2004 EST
VIENNA, Va.--(BUSINESS WIRE)--Feb. 27, 2004--H-Quotient, Inc., (OTC Bulletin
Board:HQNT) reports that its sales and technical forces are conducting the
largest round of clinical demonstrations in the Company's history, and that the
pipeline for future demonstrations is filling up. Such demonstrations are
significant, comprehensive events that require a substantial organizational and
time commitment by clinics, and as such are the primary precursors of increased
sales.

The Company has booked and is conducting clinical demonstrations across the
country. These typically include the assembly of physicians, clinical staff,
business managers, and technical personnel who are provided with in-depth
demonstrations of H-Quotient products by the Company's sales and technical
people.

The expansion of the Company's sales force has facilitated these events.

President and CEO Douglas Cohn said, "Our clinical demonstrations have
increased more than ten-fold, which is a confirmation of our products, people
and business strategy."

This announcement may contain, in addition to historical information, certain
forward-looking statements that involve risks and uncertainties. Such
statements reflect management's current views and are based on certain
assumptions. Actual results could differ materially from the assumptions
currently anticipated.

For more information visit the H-Quotient web site at www.hquotient.com.

CONTACT: H-Quotient, Inc.
Ashley Bell, 703-752-0690
abell@hquotient.com

KEYWORD: VIRGINIA PENNSYLVANIA
INDUSTRY KEYWORD: BANKING MEDICAL SOFTWARE
SOURCE: H-Quotient, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext